Literature DB >> 27841194

Visual outcome in 2000 eyes following microscopic transsphenoidal surgery for pituitary adenomas: Protracted blindness should not be a deterrent.

Pinaki Dutta1, Tenzin Gyurmey2, Reema Bansal3, Ashis Pathak4, Sivashanmugam Dhandapani2, Ashutosh Rai2, Anil Bhansali2, Kanchan Kumar Mukherjee2.   

Abstract

OBJECTIVE: To study the visual outcome after surgery for pituitary adenomas with visual deficits.
MATERIALS AND METHODS: All patients with pituitary adenoma, who presented from 2003-2014 in a tertiary care institute, were included in the study. Surgical outcome was measured in terms of difference in visual acuity, visual fields and optic fundus parameters documented before surgery, immediate post-operatively and at the third, and twelfth months following surgery.
RESULTS: At the initial presentation, visual involvement was seen in 87.2% patients. One year after surgery, 93.2% patients having abnormal vision had improvement in visual acuity and visual fields; whereas visual parameters were static in 5.2%. Visual deterioration occurred only in 1.3% patients. Moreover, five-percent of those who did not even have perception of light at presentation experienced significant improvement in vision after surgery. The shorter the duration of visual symptoms, the more was the percentage of patients having faster recovery in the early postoperative period.
CONCLUSION: Post-operative visual outcome was directly proportional to the pre-operative visual acuity. Though the visual outcome was good in the long run irrespective of the duration of symptoms, the speed of recovery was proportional to the duration of visual deficits. However, presence of long-standing visual symptoms should not deter us to subject the patient to surgery. Even patients who are completely visually impaired for years should be subjected to surgery as early as feasible.

Entities:  

Mesh:

Year:  2016        PMID: 27841194     DOI: 10.4103/0028-3886.193829

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

1.  Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas.

Authors:  Mendel Castle-Kirszbaum; Yi Yuen Wang; James King; Tony Goldschlager
Journal:  Neurosurg Rev       Date:  2021-08-09       Impact factor: 3.042

2.  Structural and functional differentiation between compressive and glaucomatous optic neuropathy.

Authors:  Poramaet Laowanapiban; Kanchalika Sathianvichitr; Niphon Chirapapaisan
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

3.  Predictive value of retinal nerve fibre layer thickness for postoperative visual improvement in patients with pituitary macroadenoma.

Authors:  Deepthi Elizabeth Kurian; Rajshekhar V; Saban Horo; Ari G Chacko; Krishna Prabhu; Gowri Mahasampath; Sanita Korah
Journal:  BMJ Open Ophthalmol       Date:  2022-07

4.  Staged endovascular treatment of a coexisting parasellar aneurysm and endoscopic resection of a pituitary macroadenoma: illustrative case.

Authors:  Aishwarya Nene; Christopher S Hong; Declan McGuone; Charles C Matouk; S Bulent Omay
Journal:  J Neurosurg Case Lessons       Date:  2022-03-07

5.  Ganglion cell inner plexiform layer thickness measured by optical coherence tomography to predict visual outcome in chiasmal compression.

Authors:  Ga-In Lee; Joonhyoung Kim; Dongyoung Lee; Kyung-Ah Park; Sei Yeul Oh; Doo-Sik Kong; Sang Duk Hong
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.